A. O. Pakulska, “DIFFERENCES IN SAFETY PROFILE AND ADVERSE EFFECTS OF ORAL AND SUBCUTANEOUS GLP-1 ANALOGUES: A SYSTEMATIC REVIEW AND REAL-WORLD DATA ANALYSIS (2024–2026)”, IJITSS, vol. 5, no. 2(50), Jun. 2026, doi: 10.31435/ijitss.2(50).2026.5685.